SOSV is a global venture capital firm that operates startup development programmes that are focused on two broad areas: revolutionary technology that promises the betterment of humanity and the planet; and cross-border markets that are ripe for explosive growth. The firm invests in a number of highly promising startups and uses its programmes to advance product development, acquire customers, and scale. SOSV’s programmes include hard-tech-oriented HAX and life-science-driven IndieBio. Both offer deep technical and regulatory expertise on-site, as well as well-equipped lab and fabrication facilities. At Chinaccelerator and MOX, market entry and product development experts help entrepreneurs win cross-border market opportunities across Asia. SOSV’s latest programme, dlab, fosters new players in the blockchain.

SOSV

HAX is a venture capital-based program dedicated to accelerating startups with a hardware element. Their program operates across two locations, San Francisco and Shenzhen, giving founders the resources necessary to move with lightning speed. Teams accepted into the program will focus on rapid iteration of prototyping in many forms. This includes physical models, technology iterations, user interaction studies, volumetric studies, marketing messaging, business plans and launch strategies. With the help of HAX’s full-time staff, mentors, partners, and startup community, they’ll also work with you on developing a scalable business plan. As teams are ready to take their  product to market, they’ll head to San Francisco to work with HAX on business development, fundraising, and growth. This stage emphasizes introductions to corporates, investors, partners and press. It also focuses on helping teams secure their first round of funding, as well as gain first-revenue and partnership traction. HAX is an SOSV program. SOSV is a global venture capital firm that operates startup venture programs around the world. SOSV had more than 1,000 portfolio companies and $950 million in assets under management.

We're Acequia Capital, a company and partnership with expertise in tech investments. We're seasoned industry partners and systems thinkers in product strategy, business models, and market entry. We're in good company with founding teams in most industries, mainly in the US, UK, and Europe.

Acequia Capital (AceCap)

Alumni Ventures Group provides high-quality, diversified venture portfolios to individual investors who previously haven't had access to VC. It helps accredited alums from top entrepreneurial schools invest together in the ventures of fellow alums. The firm backs companies with an alumni connection and an institutional lead investor with expertise in the space. AVG also offers focused funds that allow any accredited investor access to a venture portfolio, diversified by type, sector, stage, and geography. Beth Obermiller, Michael Madden, and Mike Collins co-founded the firm in Manchester, New Hampshire in 2013.

Alumni Ventures

Marinya Capital is the family office of a branch of the Fairfax family. It was originally established by Fairfax media, a large Australian media company. Marinya holds active property investments and a portfolio of investments into fund managers. Marinya Capital also makes direct private equity and venture capital investments into select opportunities.

Marinya Capital

CULT Food Science is an investment company focused on supporting and advancing the technology behind the future of food. It identifies and makes equity investments in global cultivated meat and dairy companies that are developing and commercializing innovative food technologies that enable a kinder, more secure, and more sustainable food supply chain.

Cult Food Science

C3 is investing in early-stage climate-impact startups.

Unruly is a new investment firm, aiming to find and fund the best founders building the most innovative companies at the frontiers of what's possible today. We invest early, are not scared of risky moonshots and become your biggest fans.

Unruly Capital

Unicorn Biotechnologies

Unicorn Biotechnologies is developing a next-generation biomanufacturing platform to power the cell-based manufacturing revolution, starting with cultivated meat. By providing a clear path to affordably and rapidly scale cultivated meat, we will improve human and planetary health and drive the transition to animal-free agriculture.

Unicorn Biotechnologies is a UK-based startup that specializes in novel bioreactor solutions. According to the company, its bioreactors provide fully automated seeding, passaging, perfusion, differentiation, and harvesting workflows and support all cell types. Further, it uses AI for real-time control and monitoring and provides actionable insights for process optimizations.

Making meat sustainable over the long term.

Cell-cultured Meat

Unicorn Biotechnologies is a UK-based startup that specializes in novel bioreactor solutions. According to the company, its bioreactors provide fully automated seeding, passaging, perfusion, differentiation, and harvesting workflows and support all cell types. Further, it uses AI for real-time control and monitoring and provides actionable insights for process optimizations.Funding and financialsIn <a href="https://sp-edge.com/updates/9898">April 2022</a>, Unicorn Biotechnologies raised USD 3.2 million in an oversubscribed seed funding round led by Acequia Capital. The funding was earmarked for commercialization, R&amp;D, and expansion efforts.

Mosa Meat is a Dutch cell-cultured meat startup founded by Dr. Mark Post of Maastricht University, and was the first-ever company to produce a lab-grown meat burger. The startup produces meat by growing myosatellite cells (muscle stem cells) extracted from an animal in a bioreactor fed with a nutrient-dense medium.The company replaced the fetal bovine serum (FBS) from its growth medium in July 2020, which led to an 88x cost reduction in its medium. As of March 2024, Mosa Meat operated the Center for Advanced Meat Production, Upscaling, and Sustainability (CAMPUS), a facility spanning over 79,000 sq ft that was designed to be expandable as demand grows.In <a href="https://sp-edge.com/updates/21645">September 2023</a>, Mosa Meat became the first cultivated meat company to attain B Corp certification. The company also announced plans to apply for regulatory approval in countries worldwide.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/14175">November 2022</a>, Mosa Meat entered into an agreement with Singapore-based contract development and manufacturing organization (CDMO) Esco Aster to commercialize its cultivated beef in Singapore. Further, in <a href="https://sp-edge.com/updates/16845">March 2023</a>, the company partnered withNutreco to develop a cell feed supply chain that can expedite production and scalability while reducing cost.Funding and financialsIn its latest funding round in <a href="https://sp-edge.com/updates/28536">April 2024</a>, the company raised EUR 40 million (~USD 42.5 million) in an oversubscribed funding round co-led by Lowercarbon Capital and M Ventures, with participation from PHW Group, Invest-NL, LIOF, and LEF. The funds were earmarked for scaling production procedures, reducing production costs, and gearing up for commercialization.

Mosa Meat

Eat JUST (known as Hampton Creek prior to 2018) is a food technology company that develops and sells cultivated meat products under the “GOOD Meat” brand. In December 2020, Eat JUST received approval from the Singapore Food Agency (SFA) for its cultivated chicken product and became the first ever cell-cultured meat company to commercially sell cultivated meats. GOOD Meat also received regulatory approval from the SFA for the <a href="https://sp-edge.com/updates/15768">use of serum-free media</a> in the production of cultivated meat and was among the first two companies to receive a <a href="https://sp-edge.com/updates/17221">“no questions” letter</a> from the FDA and <a href="https://sp-edge.com/updates/19588">USDA clearance</a> for the sale of cultivated chicken in the US.The company expects to reach price parity with conventional meats by 2027 and has production facilities in Germany, the US, and Singapore. The US facility can produce up to 50,000 lbs of finished products annually, while the Singapore facility, located in JTC Bedok Food City, houses Asia’s largest bioreactor for cultivated meat production.Key customers and partnershipsEat JUST partnered with several hawker food stalls in Singapore, including <a href="https://sp-edge.com/updates/8755">Loo’s Hainanese Curry Rice</a> and <a href="https://sp-edge.com/updates/10542">Kee Eng Kee</a> (KEK) to sell its cultivated meats. In <a href="https://sp-edge.com/updates/10516">May 2022</a>, the company partnered with multinational food processing company Archer Daniels Midland (ADM) to develop a low-cost growth media with ADM to leverage its expertise and technology in optimizing GOOD Meat’s existing nutrient mix. It also <a href="https://sp-edge.com/updates/10724">partnered</a> with ABEC to build a large-scale commercial facility.Funding and financialsIn<a href="https://sp-edge.com/updates/12427"> August 2022</a>, the company bagged a USD 25 million investment along with a strategic partnership from Alibaba Group-backed private equity firm C2 Capital Partners. Together, the companies are set to work toward expanding Eat JUST’s footprint in the Chinese market. Later, in <a href="https://sp-edge.com/updates/21471">September 2023</a>, the company raised an undisclosed amount in new funding led by VegInvest/Ahimsa Foundation. The funding was to be deployed towards improving the quality and profitability of Eat JUST's products.

Eat JUST

SciFi Foods (previously Artemys Foods) is a start-up developing cell-cultured beef. The startup uses pluripotent stem cells that differentiate into muscle or fat cells, which it separates into different bioreactors to cultivate. The company plans to launch a hybrid burger made from a blend of plant-based and cell-cultured meat by 2025, pending regulatory approval. Due to complexities in mimicking the texture of beef burgers, it intends to supplant its cultivated burgers with plant-based proteins.In <a href="https://sp-edge.com/updates/11598">July 2022</a>, the company announced a breakthrough in R&amp;D which allowed them to grow beef cells in single-cell line suspension leading to a reduction in cost by more than thousand fold. The company expects to reach price parity following this milestone.In <a href="https://sp-edge.com/updates/26100">January 2024</a>, SciFi Foods completed its first large-scale production of its hybrid beef product and plans to commercialize it next year after regulatory approval.Key customers and partnershipsIn<a href="https://sp-edge.com/updates/13063"> September 2022</a>, the company partnered with Michigan State University to finalize the development and test scaling of its hybrid beef burger.Funding and financialsIn<a href="https://sp-edge.com/updates/10966"> June 2022</a>, the company raised USD 22 million in a Series A funding round led by Andreessen Horowitz(a16z). The funds were earmarked for scaling up R&amp;D, attracting new hires, and marketing strategy expenses.

SCiFi Foods

SuperMeat is a cellular agriculture startup developing cultured chicken meat. The company uses chicken cells and claims to grow them in a culture medium free from antibiotics and contaminants to develop its products. SuperMeat also operates a test kitchen known as The Chicken. It is claimed to be the world’s first farm-to-fork facility where diners can observe the production of cultivated chicken.In <a href="https://sp-edge.com/updates/21733">September 2023</a>, The Orthodox Union (OU) certified SuperMeat’s cultivated chicken as “kosher.” Further, the OU and SuperMeat will collaborate on establishing guidelines for the industry.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/9319">March 2022</a>, SuperMeat signed an MoU with PHW to supply cultivated meat products including chicken, turkey, and duck to the European market. The company also <a href="https://sp-edge.com/updates/8997">partnered</a> with Ajinomoto to set up a joint venture to accelerate the commercialization of cultivated meat while focusing on developing a cost-competitive cell growth media.&nbsp;In <a href="https://sp-edge.com/updates/11867">July 2022</a>, the company signed an MoU with Switzerland’s largest retail supermarket chain and leading meat manufacturer, Migros to expedite production and distribution of cultured meat at a commercial scale with a focus on European markets.Funding and financialsIn <a href="https://sp-edge.com/updates/10945">June 2022</a> the company received grant funding from the Israel Innovation Authority to set up what claims to be the world's largest high throughput screening system for identification and optimization of cultured meat ingredients, supplemental inputs, and cellular scaffoldings for the production of cultivated meat.

SuperMeat

Uncommon (formerly HigherSteaks) is a UK-based cell-cultured meat startup that uses cellular agriculture to grow pork from animal cells. The company leverages cellular agriculture and in-house developed RNA technologies to cultivate meat and claims its technology eliminates the need for genetic engineering and growth media.In July 2020, the company unveiled the world's first lab-grown pork belly prototype and the second cell-based bacon (behind Mission Barns cell-based bacon unveiled in early 2020). The pork belly and the bacon were produced from a combination of cell-cultured muscle and plant-based proteins and fat. Uncommon plans to commercialize its cell-cultured meat by 2022-2025, pending regulatory approval.Funding and financialsIn <a href="https://sp-edge.com/updates/19267">June 2023</a>, the company raised USD 30 million in Series A funding co-led by Balderton Capital and Lower Carbon Capital, with participation from Redalpine, East Alpha, and others. The funds were earmarked for the development of its innovative approach, expanding production, increasing the team, and initiating regulatory approvals.

Uncommon

Provide sustainable solutions for animal slaughter through the use of biotechnology

Developers of bioreactors and other technologies used in cell cultured meat production. Industrial scaling and efficiency gains are key areas of interest for the startups in the industry.

Unicorn Biotechnologies

Cell-cultured Meat

Key stats

Recent Updates

Unicorn Biotechnologies raises USD 3.2 million in oversubscribed seed funding round

Company Brief

Funding

Investors

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless